Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470827) titled 'Evaluation of 'WAYMED Endo CL CS' for Automated Detection and Diagnosis of Colorectal Adenoma and Non-Adenoma Lesions' on March 9.

Study Type: Observational

Primary Sponsor: WAYCEN Inc

Condition: Colorectal Adenoma Sessile Serrated Lesion Hyperplastic Polyp Carcinoma Adenoma Non-Adenoma

Intervention: Device: WAYMED endo CL CS

Recruitment Status: Not recruiting

Date of First Enrollment: September 1, 2024

Target Sample Size: 1178

Countries of Recruitment: South Korea

To know more, visit https://clinicaltrials.gov/study/NCT07470827

Disclaimer: Curated by HT Syndication....